TG Therapeutics Inc (NASDAQ:TGTX)

13.85
Delayed Data
As of 4:00pm ET
 -0.05 / -0.36%
Today’s Change
7.25
Today|||52-Week Range
17.35
+68.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues152.4K152.4K152.4K152.4K
 
 
 
 
 
Depreciation And Amortization3.9K15.5K63.0K82.4K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses55.9M63.3M79.1M118.8M
 
 
 
 
 
Research And Development40.1M47.7M69.2M102.5M
 
 
 
 
 
Total Operating Expenses55.9M63.3M79.1M118.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-55.7M-63.2M-79.0M-118.7M
 
 
 
 
 
Extraordinary Credit720.0K1.0M995.7K786.1K
 
 
 
 
 
Interest Expense On Debt930.7K972.7K886.1K--
 
 
 
 
Other Expenses95.4K0.00283.5K-844.8K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-55.8M-62.9M-78.3M-118.5M
 
 
 
 
 
Net Income-55.8M-62.9M-78.3M-118.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS34.1M45.6M49.0M62.1M
 
 
 
 
 
Shares To Calculate EPS Diluted34.1M45.6M49.0M62.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.64-$1.38-$1.60-$1.91
 
 
 
 
 
EPS Diluted-$1.64-$1.38-$1.60-$1.91